Skip to main content
. 2021 Nov 9;12(4):623–632. doi: 10.1016/j.jaim.2021.06.001

Table 3.

Effect of WSE, WSE + Protein, protein, RT and reference on BGL and HOMA-IR.

Treatment Groups Glucose Levels (mg/dl)
Day 1 Day 15 Day 30 Day 45 Day 60
Young Control 103.50 ± 5.04 111.67 ± 4.05 116.33 ± 0.57 119.67 ± 4.82 118.33 ± 3.46
Aging Control 98.50 ± 4.03 150.50 ± 02.23a 154.17 ± 0.31b 159.00 ± 9.01b 161.33 ± 7.89a
WSE 94.17 ± 2.42 129.00 ± 4.62e 110.17 ± 0.96c 106.17 ± 2.63c 98.00 ± 2.76c
WSE + Protein 103.33 ± 2.36 132.00 ± 2.83 112.00 ± 0.28d 105.67 ± 4.91c 93.33 ± 2.07c
Protein 102.83 ± 1.62 132.33 ± 3.10 124.50 ± 0.22 111.50 ± 6.14c 105.50 ± 3.73c
RT 100.33 ± 5.80 130.50 ± 4.64e 121.33 ± 0.23e 116.50 ± 7.74c 112.50 ± 2.40c
Reference 91.66 ± 2.95 134.83 ± 5.90 114.17 ± 0.73d 108.83 ± 7.64c 99.00 ± 5.52c

Note: All values are expressed as mean ± SEM; N = 6 in each group; One way ANOVA followed by Bonferroni's multiple comparison test is applied for statistical analysis.

a

P < 0.001 when Aging Control compared with Young Control.

b

P < 0.01 when Aging Control compared with Young Control.

c

P < 0.001 when treatment groups compared with Aging control.

d

P < 0.01 when treatment groups compared with Aging control.

e

P < 0.05 when treatment groups compared with Aging control.